Table 3.
Baseline, Follow-up, and Baseline-adjusted Follow-up Data for Outcome Measures for the Three Intervention Groups for Participants with Migraine Headaches (n = 90)
| Variable | Relaxation (n = 28) | Disclosure (n = 31) | Control (n = 31) |
|---|---|---|---|
| Headache frequency | |||
| Baseline | 9.86 (6.21) | 9.65 (6.46) | 11.77(7.58) |
| Follow-up | 9.36 (6.13) | 9.00 (5.81) | 8.97 (6.14) |
| Adjusted follow-up | 9.63 (0.98) | 9.37 (0.93) | 8.35 (0.94) |
| Headache severity | |||
| Baseline | 6.57 (1.57) | 6.39 (1.52) | 6.35(1.14) |
| Follow-up | 4.68 (2.13) | 5.23 (2.28) | 5.55 (1.69) |
| Adjusted follow-up | 4.60 (0.36) | 5.25 (0.34) | 5.60 (0.34) |
| Headache disability | |||
| Baseline | 12.11 (8.88) | 13.35 (11.83) | 15.35 (12.25) |
| Follow-up | 9.89 (12.91) | 9.87 (8.79) | 10.13 (11.49) |
| Adjusted follow-up | 10.81 (1.71) | 10.05 (1.62) | 9.13 (1.63) |
| Physical symptoms | |||
| Baseline | 15.50 (8.32) | 12.39 (4.94) | 13.48 (5.16) |
| Follow-up | 13.32 (7.82) | 11.26 (7.61) | 10.61 (5.37) |
| Adjusted follow-up | 12.15 (1.08) | 12.15 (1.02) | 10.78 (1.02) |
Baseline and follow-up data are mean (standard deviation), and adjusted follow-up data are mean (standard error of the mean) of the follow-up value, adjusted for the baseline value.